Aurora Labs Ltd. (AU:A3D)
ASX:A3D
Want to see AU:A3D full AI Analyst Report?
Top Page
Aurora Labs
(Sydney:A3D)
Select Model
Select Model
Rating:50Neutral
Price Target:
AU$0.05
â–¼(-18.33% Downside)
Action:Reiterated
Date:02/13/26
The score is held back primarily by weak financial quality—ongoing losses, negative operating cash flow, and higher leverage—despite strong top-line growth. Technicals are a meaningful offset, with price and momentum indicators signaling a solid uptrend. Valuation remains constrained because the company is loss-making (negative P/E) and no dividend yield is provided.
Positive Factors
Top-line Growth
Aurora's 183.75% revenue growth signals meaningful traction for its metal 3D printing technology and software. Sustained top-line expansion strengthens scale economics, increases customer validation, and provides a larger base to leverage R&D and fixed-cost absorption over the medium term.
Negative Factors
Persistent Losses
Ongoing negative net and EBIT margins mean the business has yet to achieve operating profitability. Persistent losses limit internal funding for growth, pressure returns on equity, and increase the need for external capital, which can dilute shareholders and strain strategic flexibility.
Read all positive and negative factors
Positive Factors
Negative Factors
Top-line Growth
Aurora's 183.75% revenue growth signals meaningful traction for its metal 3D printing technology and software. Sustained top-line expansion strengthens scale economics, increases customer validation, and provides a larger base to leverage R&D and fixed-cost absorption over the medium term.
Read all positive factors
Aurora Labs (A3D) vs. iShares MSCI Australia ETF (EWA)
Market Cap
AU$25.66M
Dividend YieldN/A
Average Volume (3M)733.36K
Price to Earnings (P/E)―
Beta (1Y)0.74
Revenue Growth170.20%
EPS Growth4.95%
CountryAU
Employees10
SectorIndustrials
Sector Strength72
IndustryIndustrial - Machinery
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding523,619,600
10 Day Avg. Volume674,439
30 Day Avg. Volume733,357
Financial Highlights & Ratios
PEG Ratio1.94
Price to Book (P/B)13.71
Price to Sales (P/S)19.76
P/FCF Ratio-5.25
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Aurora Labs Business Overview & Revenue Model
Company Description
Aurora Labs Limited engages in the design, development, and commercialization of 3D metal printers, powders, and digital parts and its related intellectual property in Australia. It develops industrial grade 3D metal printers. The company was inco...
How the Company Makes Money
null...
Aurora Labs Financial Statement Overview
Summary
Income Statement
35
Negative
Balance Sheet
40
Negative
Cash Flow
30
Negative
| Breakdown | TTM | Jun 2025 | Jun 2024 | Jun 2023 | Jun 2022 | Jun 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 708.31K | 743.83K | 174.30K | 134.56K | 32.20K | 171.62K |
| Gross Profit | -1.37M | 326.65K | 57.13K | 58.81K | 13.89K | -145.00K |
| EBITDA | -4.77M | -4.54M | -3.23M | -3.37M | -3.70M | -4.81M |
| Net Income | -4.05M | -3.75M | -2.81M | -2.96M | -3.15M | -4.42M |
Balance Sheet | ||||||
| Total Assets | 5.77M | 2.91M | 3.08M | 2.18M | 3.35M | 2.91M |
| Cash, Cash Equivalents and Short-Term Investments | 3.65M | 1.16M | 1.65M | 986.80K | 1.95M | 1.37M |
| Total Debt | 232.00K | 956.01K | 842.94K | 65.39K | 160.53K | 252.00K |
| Total Liabilities | 1.40M | 1.84M | 1.30M | 719.35K | 716.58K | 711.20K |
| Stockholders Equity | 4.37M | 1.07M | 1.78M | 1.46M | 2.63M | 2.20M |
Cash Flow | ||||||
| Free Cash Flow | -4.21M | -2.80M | -2.41M | -2.60M | -2.68M | -1.68M |
| Operating Cash Flow | -3.22M | -2.62M | -2.40M | -2.57M | -2.63M | -1.68M |
| Investing Cash Flow | -988.63K | -180.58K | -7.69K | -23.07K | -48.42K | 6.86K |
| Financing Cash Flow | 5.68M | 2.31M | 3.07M | 1.63M | 3.25M | 1.72M |
Aurora Labs Technical Analysis
Negative
0.06
Price Trends
0.05
Negative
0.05
Negative
0.05
Negative
Market Momentum
>-0.01
Positive
41.83
Neutral
44.44
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For AU:A3D, the sentiment is Negative. The current price of 0.06 is above the 20-day moving average (MA) of 0.05, above the 50-day MA of 0.05, and above the 200-day MA of 0.05, indicating a bearish trend. The MACD of >-0.01 indicates Positive momentum. The RSI at 41.83 is Neutral, neither overbought nor oversold. The STOCH value of 44.44 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for AU:A3D.
Aurora Labs Peers Comparison
UnderperformOutperform
Sector (63)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
68 Neutral | AU$65.81M | 8.31 | 12.00% | 1.92% | 9.98% | 70.40% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
50 Neutral | AU$25.66M | -2.24 | -148.94% | ― | 170.20% | 4.95% | |
47 Neutral | AU$328.57M | -19.19 | -68.32% | ― | -9.99% | -245.74% | |
45 Neutral | AU$353.34M | -5.06 | -99.54% | ― | 13.94% | -84.03% | |
44 Neutral | AU$309.81M | -3.91 | -39.81% | ― | 393.65% | 2.58% | |
41 Neutral | AU$91.83M | -4.86 | -29.37% | ― | -42.46% | -64.36% |
* Industrials Sector Average
AU:A3D
Aurora Labs
0.05
<0.01
4.00%
AU:TTT
Titomic Ltd
0.22
-0.09
-29.03%
AU:AL3
AML3D Ltd
0.16
>-0.01
-3.13%
AU:MPW
Metal Powder Works Limited
2.28
1.63
250.77%
AU:3DA
Amaero International Ltd
0.33
0.06
22.22%
AU:LBL
Laserbond Limited
0.56
0.19
52.17%
Aurora Labs Corporate Events
Aurora Labs Deepens Defence Push as Propulsion Pipeline and Manufacturing Capacity Grow
Apr 22, 2026
Aurora Labs reported continued progress in commercialising its metal additive manufacturing and turbojet propulsion technologies during the March quarter, driven by defence-aligned initiatives and growing international engagement. The company adva...
Aurora Labs Grants 2.5 Million Unlisted Options to Director
Apr 10, 2026
Aurora Labs Limited has reported a change in the securities held by director Andrew Bottrell, reflecting the issuance of new unlisted director options rather than any on-market trading activity.Following shareholder approval on 9 April 2026, Bottr...
Aurora Labs Issues New Option Package to Director Rebekah Letheby
Apr 10, 2026
Aurora Labs has disclosed a change in director Rebekah Letheby’s interests following the issue of 7.5 million unlisted director options. The options, approved by shareholders on 9 April 2026, are exercisable at $0.14 each before 10 April 202...
Aurora Labs Grants Additional Unlisted Options to Director
Apr 10, 2026
Aurora Labs has reported a change in director Andrew Garth’s interests, following shareholder approval for the issue of additional unlisted director options. The filing details that Garth has been granted 7,500,000 unlisted options exercisab...
Aurora Labs Issues 25 Million Unquoted Director Options
Apr 10, 2026
Aurora Labs Limited has notified the market of the issue of 25 million unquoted Director Options, dated 10 April 2026, under an Appendix 3G filing to the ASX. The options, which form part of a previously announced transaction and are not intended ...
Aurora Labs Strengthens Governance With New Company Secretary
Apr 1, 2026
Aurora Labs has announced a change in its company secretary, with Grant Mooney resigning effective 10 April 2026 and Stephen Buckley stepping into the role. Buckley, a director at Governance Corporate, brings more than four decades of financial ma...
Aurora Labs Director Increases Indirect Shareholding via On-Market Trade
Mar 17, 2026
Aurora Labs Limited has reported a change in director David Trimboli’s interests, detailing additional ordinary shares acquired through his investment vehicle, Seefeld Investments Pty Ltd. Following an on-market trade on 16 March 2026, Seefe...
Aurora Labs Plans Issue of 28 Million Unlisted Options for Capital Raising
Mar 10, 2026
Aurora Labs Limited has notified the ASX of a proposed issue of up to 28 million unlisted options as part of a placement or similar capital-raising mechanism. The options, which form a new class of unlisted securities, are scheduled for issue on 9...
Aurora Labs Moves to Digital Communication for April Shareholder Meeting
Mar 9, 2026
Aurora Labs has called a general meeting of shareholders for 9 April 2026 in Perth, where resolutions will be decided by poll based on both proxy votes and those of shareholders attending in person. The company is shifting to primarily digital dis...
Aurora Labs Calls April 2026 Meeting to Vote on Director Option Grant
Mar 9, 2026
Aurora Labs Limited has called a general meeting of shareholders to be held in Perth on 9 April 2026, with proxy votes due by 7 April 2026, to consider key governance and remuneration matters. The main item on the agenda is shareholder approval fo...
Aurora Labs Appoints New Director With No Current Equity Stake
Mar 8, 2026
Aurora Labs Ltd has appointed Andrew Bottrell as a director effective 4 March 2026, according to an initial director’s interest notice lodged with the ASX. The filing shows that Bottrell holds no relevant interests in Aurora Labs securities,...
Aurora Labs Adds Senior Defence Leader to Board to Bolster Growth in Defence Markets
Mar 4, 2026
Aurora Labs has strengthened its board with the appointment of retired Major General Andrew Bottrell as a non-executive director, effective 5 March 2026, adding nearly four decades of senior defence and national security experience. Bottrell bring...
Aurora Labs Issues New Shares Under Employee Incentive Scheme
Mar 3, 2026
Aurora Labs has issued 259,924 fully paid ordinary shares as a result of the conversion of an equivalent number of share rights granted under its Employee Incentive Scheme. The move modestly increases the company’s share capital while reinfo...
Aurora Labs Director Increases Equity Stake via Share Rights Conversion
Mar 3, 2026
Aurora Labs has disclosed a change in director David Trimboli’s interests, following the issue and subsequent conversion of 259,924 share rights into ordinary shares. The transaction, valued at $11,956.52, increased Trimboli’s direct h...
Aurora Labs Seeks ASX Quotation for Additional Ordinary Shares
Mar 3, 2026
Aurora Labs Limited has applied for quotation on the ASX of 259,924 new ordinary fully paid shares, to be issued on March 3, 2026, under its existing ticker A3D. The additional securities arise from the exercise or conversion of existing options o...
Aurora Labs Issues 259,924 Unquoted Share Rights Under Employee Scheme
Feb 27, 2026
Aurora Labs Limited has notified the market of the issue of 259,924 unquoted share rights under an employee incentive scheme, with an issue date of 27 February 2026. These securities are not intended to be quoted on the ASX, indicating the company...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.